Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole (2015)
- Authors:
- Autor USP: ISHIDA, KELLY - ICB
- Unidade: ICB
- DOI: 10.1099/jmm.0.000041
- Subjects: MICROBIOLOGIA; ESPOROTRICOSE; ESPOROS BACTERIANOS; INFECÇÔES BACTERIANAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Medical Microbiology
- ISSN: 1473-5644
- Volume/Número/Paginação/Ano: v. 64, p. 415-422, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
BORBA-SANTOS, Luana Pereira et al. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole. Journal of Medical Microbiology, v. 64, p. 415-422, 2015Tradução . . Disponível em: https://doi.org/10.1099/jmm.0.000041. Acesso em: 11 jun. 2024. -
APA
Borba-Santos, L. P., Gagini, T., Ishida, K., Souza, W. de, & Rozental, S. (2015). Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole. Journal of Medical Microbiology, 64, 415-422. doi:10.1099/jmm.0.000041 -
NLM
Borba-Santos LP, Gagini T, Ishida K, Souza W de, Rozental S. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole [Internet]. Journal of Medical Microbiology. 2015 ; 64 415-422.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1099/jmm.0.000041 -
Vancouver
Borba-Santos LP, Gagini T, Ishida K, Souza W de, Rozental S. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole [Internet]. Journal of Medical Microbiology. 2015 ; 64 415-422.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1099/jmm.0.000041 - Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil
- Synergistic antifungal interaction between Pseudomonas aeruginosa LV strain metabolites and biogenic silver nanoparticles against Candida auris
- Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis
- Δ(24)-sterol methyltransferase plays an important role in the growth and development of Sporothrix schenckii and Sporothrix brasiliensis
- Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine
- Adamantylidene-substituted alkylphosphocholine TCAN26 is more active against Sporothrix schenckii than miltefosine
- Performance of methods for identification of yeasts isolated from blotted water: High prevalence of Candida parapsilosis
- Silver nanoparticle production by the fungus Fusarium oxysporum: nanoparticle characterisation and analysis of antifungal activity against pathogenic yeasts
- Alternative treatment of fungal infections: synergy with non‐antifungal agents
- Amphotericin B, alone or followed by itraconazole therapy, is effective in the control of experimental disseminated sporotrichosis by Sporothrix brasiliensis
Informações sobre o DOI: 10.1099/jmm.0.000041 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas